Clinical Trials on Hyperparathyroidism
Total 478 results
-
Papageorgiou General HospitalCompletedSecondary Hyperparathyroidism
-
Josep M CruzadoCompletedSecondary HyperparathyroidismSpain
-
Mario Negri Institute for Pharmacological ResearchCompletedRenal Transplant | Secondary HyperparathyroidismItaly
-
Washington University School of MedicineActive, not recruiting
-
Istituto Auxologico ItalianoCompletedHyperparathyroidism, Primary | OsteoporosisItaly
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPrimary Hyperparathyroidism | Vitamin D DeficiencyUnited States
-
Medical University of ViennaNational Bank of AustriaCompletedPrimary Hyperparathyroidism | Osteoporosis | OsteopeniaAustria
-
AmgenCompletedHyperparathyroidism | Parathyroid Neoplasms
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
Emory UniversityTerminatedHyperparathyroidism, SecondaryUnited States
-
University of PennsylvaniaActive, not recruitingPrimary Hyperparathyroidism | Osteoporosis, PostmenopausalUnited States
-
ProMedica Health SystemUniversity of Toledo Health Science CampusUnknownPrimary Hyperparathyroidism | HypercalcemiaUnited States
-
Roxane LaboratoriesCompletedHypocalcemia | Secondary HyperparathyroidismUnited States
-
Penang Hospital, MalaysiaMinistry of Health, MalaysiaCompletedHyperparathyroidism | Kidney DiseaseMalaysia
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Completed
-
LEO PharmaCompletedSecondary HyperparathyroidismGermany, Poland
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Secondary Hyperparathyroidism | Stage 5 Chronic Kidney Diseases
-
AmgenCompletedSecondary Hyperparathyroidism in Patients With ESRD on HemodialysisUnited States
-
AmgenCompletedSecondary Hyperparathyroidism, Chronic Kidney DiseaseUnited States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
-
AmgenTerminatedChronic Kidney Disease, Secondary HyperparathyroidismUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
-
AmgenCompletedChronic Kidney Disease, Secondary HyperparathyroidismBelgium, United States, Germany, Poland, United Kingdom, Lithuania
-
The Cleveland ClinicRecruitingPrimary Hyperparathyroidism | Type 2 DiabetesUnited States
-
Weill Medical College of Cornell UniversityCompletedObesity | Vitamin D Deficiency | Secondary HyperparathyroidismUnited States
-
Skane University HospitalKarolinska University HospitalCompletedSecondary Hyperparathyroidism | Disorder Related to Renal Transplantation
-
Chulalongkorn UniversityCompletedHyperparathyroidism, SecondaryThailand
-
AmgenRecruitingSecondary HyperparathyroidismSpain, Belgium, Germany, Czechia, Poland, France, Greece, Hungary, Italy, United Kingdom, Lithuania, Portugal
-
Genzyme, a Sanofi CompanyCompletedSecondary HyperparathyroidismUnited States
-
AmgenCompletedSecondary Hyperparathyroidism
-
Hospices Civils de LyonCompletedHyperparathyroidism | Hypoparathyroidism | Fibrous Dysplasia | Adult Children | Pseudo Hypoparathyroidism | Albright SyndromeFrance
-
Karolinska University HospitalWithdrawnDiabetes | Hyperparathyroidism | HypercalcemiaSweden
-
Duke UniversityUniversity of California, Los Angeles; University of ArkansasWithdrawn
-
University Health Network, TorontoCompletedHyperparathyroidism, Primary | Positron-Emission Tomography | 18F-fluorocholineCanada
-
SanofiActive, not recruitingSecondary Hyperparathyroidism-Chronic Kidney DiseaseUnited States, Chile
-
Astellas Pharma IncCompletedSecondary HyperparathyroidismJapan
-
University of AarhusCompletedPrimary Hyperparathyroidism | Vitamin D Deficiency | HypercalcemiaDenmark
-
AbbVie (prior sponsor, Abbott)AlmedisCompletedSecondary HyperparathyroidismRussian Federation
-
Atlanta VA Medical CenterEmory UniversityCompletedKidney DiseaseUnited States
-
AbbottCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
IHU StrasbourgTerminatedPrimary Hyperparathyroidism
-
Montefiore Medical CenterTerminatedSecondary Hyperparathyroidism | HypercalcemiaUnited States
-
Creighton UniversityGlaxoSmithKlineCompletedOsteoporosis | Secondary Hyperparathyroidism
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedPrimary Hyperparathyroidism | Bone Diseases, Metabolic | Osteoporosis, Postmenopausal | Bone Loss, PostmenopausalUnited States
-
Mansoura General HospitalCompletedHyperparathyroidism TertiaryEgypt
-
Centre Francois BaclesseFondation de l'AvenirCompletedHyperparathyroidism | Parathyroid Adenoma | F18-cholineFrance
-
AmgenCompletedChronic Kidney Disease | Secondary Hyperparathyroidism
-
University of Colorado, DenverCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
Kenneth R. Phelps, M.D.Genzyme, a Sanofi CompanyCompletedHyperparathyroidism | Chronic Kidney DiseaseUnited States
-
AmgenCompletedChronic Kidney Disease | Kidney Disease
-
Amolyt PharmaRecruitingEndocrine System Diseases | Parathyroid Diseases | Chronic HypoparathyroidismGermany, United States, Spain, Italy, Denmark, United Kingdom, Hungary, France, Netherlands, Canada, Portugal, Poland
-
Amolyt PharmaCompletedChronic HypoparathyroidismHungary, Netherlands